Trial NCT02194374

View at ClinicalTrials.gov 
Org. Study IDs: 2012-0932
Secondary IDs: NCI-2014-01715

Last trial update was posted on 2017-06-12

MeSH Interventions

Bendamustine Hydrochloride Cyclophosphamide Fludarabine Fludarabine phosphate Rituximab

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions


Stopping Reasons

Study closed with no enrollment due to unavailability of reagent.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID